Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ·Healthcare·Biotechnology
$2.73
+13.69%
Mkt Cap $183.65M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+83.2%
Consensus $5.00 vs current $2.73
NASDAQ·Healthcare·Biotechnology
$2.73
+13.69%
Mkt Cap $183.65M
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
+83.2%
Consensus $5.00 vs current $2.73